33 results on '"Lembo, David"'
Search Results
2. Identification of oxysterol synthetic analogs as a novel class of late-stage inhibitors of herpes simplex virus 2 replication
- Author
-
Civra, Andrea, Costantino, Matteo, Ronchi, Giulia, Pontini, Lorenzo, Poli, Giuseppe, Marinozzi, Maura, and Lembo, David
- Published
- 2023
- Full Text
- View/download PDF
3. The role of bacteria and viruses in Behçet syndrome: Should we move towards new paradigms?
- Author
-
Sciascia, Savino, Arbrile, Marta, Trunfio, Mattia, Calcagno, Andrea, Radin, Massimo, Roccatello, Dario, Lembo, David, and Civra, Andrea
- Published
- 2023
- Full Text
- View/download PDF
4. Acyclovir-loaded sulfobutyl ether-β-cyclodextrin decorated chitosan nanodroplets for the local treatment of HSV-2 infections
- Author
-
Donalisio, Manuela, Argenziano, Monica, Rittà, Massimo, Bastiancich, Chiara, Civra, Andrea, Lembo, David, and Cavalli, Roberta
- Published
- 2020
- Full Text
- View/download PDF
5. The cholesterol metabolite 27-hydroxycholesterol inhibits SARS-CoV-2 and is markedly decreased in COVID-19 patients
- Author
-
Marcello, Alessandro, Civra, Andrea, Milan Bonotto, Rafaela, Nascimento Alves, Lais, Rajasekharan, Sreejith, Giacobone, Chiara, Caccia, Claudio, Cavalli, Roberta, Adami, Marco, Brambilla, Paolo, Lembo, David, Poli, Giuseppe, and Leoni, Valerio
- Published
- 2020
- Full Text
- View/download PDF
6. Auto-associative heparin nanoassemblies: A biomimetic platform against the heparan sulfate-dependent viruses HSV-1, HSV-2, HPV-16 and RSV
- Author
-
Lembo, David, Donalisio, Manuela, Laine, Claire, Cagno, Valeria, Civra, Andrea, Bianchini, Elsa P., Zeghbib, Narimane, and Bouchemal, Kawthar
- Published
- 2014
- Full Text
- View/download PDF
7. Micro- and nanobubbles: A versatile non-viral platform for gene delivery
- Author
-
Cavalli, Roberta, Bisazza, Agnese, and Lembo, David
- Published
- 2013
- Full Text
- View/download PDF
8. Enhanced antiviral activity of Acyclovir loaded into β-cyclodextrin-poly(4-acryloylmorpholine) conjugate nanoparticles
- Author
-
Cavalli, Roberta, Donalisio, Manuela, Civra, Andrea, Ferruti, Paolo, Ranucci, Elisabetta, Trotta, Francesco, and Lembo, David
- Published
- 2009
- Full Text
- View/download PDF
9. Preparation and in vitro evaluation of the antiviral activity of the Acyclovir complex of a β-cyclodextrin/poly(amidoamine) copolymer
- Author
-
Bencini, Marco, Ranucci, Elisabetta, Ferruti, Paolo, Trotta, Francesco, Donalisio, Manuela, Cornaglia, Maura, Lembo, David, and Cavalli, Roberta
- Published
- 2008
- Full Text
- View/download PDF
10. The anticytomegaloviral activity of raltitrexed is abrogated in quiescent mouse fibroblasts that overexpress thymidylate synthase
- Author
-
Gribaudo, Giorgio, Riera, Ludovica, Lembo, David, De Andrea, Marco, Johnson, Lee F, and Landolfo, Santo
- Published
- 2001
- Full Text
- View/download PDF
11. The thymidylate synthase inhibitor ZD1694 potently inhibits murine and human cytomegalovirus replication in quiescent fibroblasts
- Author
-
Lembo, David, Gribaudo, Giorgio, Riera, Ludovica, Mondo, Alessandra, Cavallo, Rossana, Angeretti, Alessandra, and Landolfo, Santo
- Published
- 2000
- Full Text
- View/download PDF
12. Oxysterols: An emerging class of broad spectrum antiviral effectors.
- Author
-
Lembo, David, Cagno, Valeria, Civra, Andrea, and Poli, Giuseppe
- Subjects
- *
OXYSTEROLS , *ANTIVIRAL agents , *STEROLS , *HYDROXYL group , *VIRAL replication , *BILAYER lipid membranes - Abstract
Oxysterols are a family of cholesterol oxidation derivatives that contain an additional hydroxyl, epoxide or ketone group in the sterol nucleus and/or a hydroxyl group in the side chain. The majority of oxysterols in the blood are of endogenous origin, derived from cholesterol via either enzymatic or non-enzymatic mechanisms. A large number of reports demonstrate multiple physiological roles of specific oxysterols. One such role is the inhibition of viral replication. This biochemical/biological property was first characterised against a number of viruses endowed with an external lipid membrane (enveloped viruses), although antiviral activity has since been observed in relation to several non-enveloped viruses. In the present paper, we review the recent findings about the broad antiviral activity of oxysterols against enveloped and non-enveloped human viral pathogens, and provide an overview of their putative antiviral mechnism(s). [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
13. Encapsulation of Acyclovir in new carboxylated cyclodextrin-based nanosponges improves the agent's antiviral efficacy
- Author
-
Lembo, David, Swaminathan, Shankar, Donalisio, Manuela, Civra, Andrea, Pastero, Linda, Aquilano, Dino, Vavia, Pradeep, Trotta, Francesco, and Cavalli, Roberta
- Subjects
- *
ACYCLOVIR , *MICROENCAPSULATION , *CARBOXYLATION , *CYCLODEXTRINS , *ANTIVIRAL agents , *DRUG efficacy - Abstract
Abstract: Cyclodextrin-based nanosponges (NS) are solid nanoparticles, obtained from the cross-linking of cyclodextrins that have been proposed as delivery systems for many types of drugs. Various NS derivatives are currently under investigation in order that their properties might be tuned for different applications. In this work, new carboxylated cyclodextrin-based nanosponges (Carb-NS) carrying carboxylic groups within their structure were purposely designed as novel Acyclovir carriers. TEM measurements revealed their spherical shape and size of about 400nm. The behaviour of Carb-NS, with respect to the incorporation and delivery of Acyclovir, was compared to that of NS, previously investigated as a drug carrier. DSC, XRPD and FTIR analyses were used to investigate the two NS formulations. The results confirm the incorporation of the drug into the NS structure and NS-Acyclovir interactions. The Acyclovir loading into Carb-NS was higher than that obtained using NS, reaching about 70% (w/w). In vitro release studies showed the release kinetics of Acyclovir from Carb-NS to be prolonged in comparison with those observed with NS, with no initial burst effect. The NS uptake into cells was evaluated using fluorescent Carb-NS and revealed the nanoparticle internalisation. Enhanced antiviral activity against a clinical isolate of HSV-1 was obtained using Acyclovir loaded in Carb-NS. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
14. Early inhibitors of human cytomegalovirus: State-of-art and therapeutic perspectives
- Author
-
Mercorelli, Beatrice, Lembo, David, Palù, Giorgio, and Loregian, Arianna
- Subjects
- *
CYTOMEGALOVIRUS diseases , *DNA polymerases , *NEWBORN infant development , *GENETIC disorders , *HIV-positive persons , *DRUG resistance in microorganisms , *BIOAVAILABILITY , *VIRAL replication , *IMMUNOREGULATION - Abstract
Abstract: Human cytomegalovirus (HCMV) infection is associated with severe morbidity and mortality in immunocompromised individuals, mainly transplant recipients and AIDS patients, and is the most frequent cause of congenital malformations in newborn children. To date, few drugs are licensed for the treatment of HCMV infections, most of which target the viral DNA polymerase and suffer from many drawbacks, including long-term toxicity, low potency, and poor bioavailability. In addition, the emergence of drug-resistant viral strains is becoming an increasing problem for disease management. Finally, none of the current anti-HCMV drugs have been approved for the treatment of congenital infections. For all these reasons, there is still a strong need for new anti-HCMV drugs with novel mechanisms of action. The first events of the virus replication cycle, including attachment, entry, immediate-early gene expression, and immediate-early functions—in particular that of Immediate-Early 2 protein—represent attractive targets for the development of novel antiviral compounds. Such inhibitors would block not only the expression of viral immediate-early proteins, which play a key role in the pathogenesis of HCMV infection, but also the host immunomodulation and the changes to cell physiology induced by the first events of virus infection. This review describes the current knowledge on the initial phases of HCMV replication, their validation as potential novel antiviral targets, and the development of compounds that block such processes. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
15. Tinkering with a viral ribonucleotide reductase
- Author
-
Lembo, David and Brune, Wolfram
- Subjects
- *
DNA viruses , *VIRAL evolution , *BIOSYNTHESIS , *INFLAMMATION , *CELLULAR signal transduction , *CATALYTIC RNA , *NATURAL immunity - Abstract
Ribonucleotide reductase (RNR), a crucial enzyme for nucleotide anabolism, is encoded by all living organisms and by large DNA viruses such as the herpesviruses. Surprisingly, the β-herpesvirus subfamily RNR R1 subunit homologues are catalytically inactive and their function remained enigmatic for many years. Recent work sheds light on the function of M45, the murine cytomegalovirus R1 homologue; during viral evolution, M45 apparently lost its original RNR activity but gained the ability, via inhibiting RIP1, a cellular adaptor protein, to block cellular signaling pathways involved in innate immunity and inflammation. The discovery of this novel mechanism of viral immune subversion provides further support to the concept of evolutionary tinkering. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
16. Effect of high-risk human papillomavirus oncoproteins on p53R2 gene expression after DNA damage
- Author
-
Lembo, David, Donalisio, Manuela, Cornaglia, Maura, Azzimonti, Barbara, Demurtas, Anna, and Landolfo, Santo
- Subjects
- *
DNA damage , *NUCLEIC acids , *BIOCHEMICAL genetics , *GENETIC mutation - Abstract
Abstract: The p53R2 protein is a p53-inducible small subunit of ribonucleotide reductase. It plays a crucial role in p53-dependent cellular response to DNA damage and oxidative stress by providing deoxyribonucleotides (dNTPs) to the DNA repair machinery and by scavenging reactive oxygen species (ROS). To investigate the effects of high-risk human papillomavirus (HPV) oncoproteins on p53R2 expression after DNA damage, we analyzed the p53R2 protein levels in human cells ectopically expressing the HPV-16 E6 and E7 genes, and in the HPV-positive cancer cell lines SiHa, CaSki and HeLa, exposed to adriamycin or to H2O2. We found that in normal cells, p53R2 expression is efficiently induced by both H2O2 and adriamycin, supporting the role of p53R2 in cellular response to oxidative stress. Ectopic expression of E6 impaired p53 and p53R2 induction after DNA damage in human fibroblasts. Moreover, SiHa, CaSki and HeLa cells were unresponsive to H2O2 exposure, and adriamycin induced p53R2 levels only in SiHa cells. Our results imply that high-risk HPV infection may suppress the p53R2-dependent dNTPs supply to the DNA repair system and the ROS scavenging activity; they also suggest that an altered p53R2 response to genotoxins and to oxidative stress may contribute to HPV-induced genetic instability and carcinogenesis. [Copyright &y& Elsevier]
- Published
- 2006
- Full Text
- View/download PDF
17. Hexagonal-shaped chondroitin sulfate self-assemblies have exalted anti-HSV-2 activity.
- Author
-
Galus, Aurélia, Mallet, Jean-Maurice, Lembo, David, Cagno, Valeria, Djabourov, Madeleine, Lortat-Jacob, Hugues, and Bouchemal, Kawthar
- Subjects
- *
CHONDROITIN , *MOLECULAR self-assembly , *HERPES simplex virus , *GLYCOSAMINOGLYCANS , *MUCOUS membrane diseases , *BIOMIMETIC chemicals - Abstract
The initial step in mucosal infection by the herpes simplex virus type 2 (HSV-2) requires its binding to certain glycosaminoglycans naturally present on host cell membranes. We took advantage of this interaction to design biomimetic supramolecular hexagonal-shaped nanoassemblies composed of chondroitin sulfate having exalted anti-HSV-2 activity in comparison with native chondroitin sulfate. Nanoassemblies were formed by mixing hydrophobically-modified chondroitin sulfate with α-cyclodextrin in water. Optimization of alkyl chain length grafted on chondroitin sulfate and the ratio between hydrophobically-modified chondroitin sulfate and α-cyclodextrin showed that more cohesive and well-structured nanoassemblies were obtained using higher α-cyclodextrin concentration and longer alkyl chain lengths. A structure-activity relationship was found between anti-HSV-2 activity and the amphiphilic nature of hydrophobically-modified chondroitin sulfate. Also, antiviral activity of hexagonal nanoassemblies against HSV-2 was further improved in comparison with hydrophobically-modified chondroitin sulfate. This work suggests a new biomimetic formulation approach that can be extended to other heparan-sulfate-dependent viruses. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
18. Modulation of cell proteome by 25-hydroxycholesterol and 27-hydroxycholesterol: A link between cholesterol metabolism and antiviral defense.
- Author
-
Civra, Andrea, Colzani, Mara, Cagno, Valeria, Francese, Rachele, Leoni, Valerio, Aldini, Giancarlo, Lembo, David, and Poli, Giuseppe
- Subjects
- *
PROTEOMICS , *METABOLIC regulation , *OXYSTEROLS , *CELL analysis , *RADIOLABELING , *CHOLESTEROL metabolism , *HYDROXYCHOLESTEROLS - Abstract
Physiological cholesterol metabolism implies the generation of a series of oxidized derivatives, whose oxysterols are by far the most investigated ones for their potential multifaceted involvement in human pathophysiology. In this regard, noteworthy is the broad antiviral activity displayed by defined side chain oxysterols, in particular 25-hydroxycholesterol (25HC) and 27-hydroxycholesterol (27HC). Although their antiviral mechanism(s) may vary depending on virus/host interaction, these oxysterols share the common feature to hamper viral replication by interacting with cellular proteins. Here reported is the first analysis of the modulation of a cell proteome by these two oxysterols, that, besides yielding additional clues about their potential involvement in the regulation of sterol metabolism, provides novelinsights about the mechanism underlying the inhibition of virus entry and trafficking within infected cells. We show here that both 25HC and 27HC can down-regulate the junction adhesion molecule-A (JAM-A) and the cation independent isoform of mannose-6-phosphate receptor (MPRci), two crucial molecules for the replication of all those viruses that exploit adhesion molecules and the endosomal pathway to enter and diffuse within target cells. Image 1 • 25HC and 27HC, two physiological products of enzymatic cholesterol oxidation, modulate the proteome of HeLa cells, standard model system. • Cell proteome analysis was afforded by coupling mass spectrometry to stable isotope labelling by amino acids in cell culture (SILAC) technology. • The large majority of proteins significantly modulated by both 25HC and 27HC is related to sterol synthesis and metabolism. • Down-regulation of JAM-A and MPRci likely contributes to the broad antiviral activity of 25HC and 27HC. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
19. Colostrum from cows immunized with a veterinary vaccine against bovine rotavirus displays enhanced in vitro anti-human rotavirus activity.
- Author
-
Civra, Andrea, Altomare, Alessandra, Francese, Rachele, Donalisio, Manuela, Aldini, Giancarlo, and Lembo, David
- Subjects
- *
CATTLE , *VETERINARY vaccines , *COLOSTRUM , *COWS , *ORAL vaccines , *ROTAVIRUS vaccines - Abstract
Human rotaviruses represent a major cause of severe diarrheal disease in infants and young children. The limited impact of oral vaccines on global estimates of rotavirus mortality and the suboptimal use of oral rehydration justify the need for alternative prophylactic and therapeutic strategies, especially for immunocompromised hosts. The protective effects of colostrum—the first milk produced during the initial 24 to 48 h after parturition—are well documented in the literature. In particular, the ingestion of hyperimmune bovine colostrum has been proposed as an alternative preventive approach against human rotavirus gastroenteritis. Although the immunization of pregnant cows with human rotavirus boosts the release of specific immunoglobulin G in bovine colostrum, it raises regulatory and safety issues. In this study, we demonstrated that the conventional bovine rotavirus vaccine is sufficient to enhance the anti-human rotavirus protective efficacy of bovine colostrum, thus providing a conservative approach to produce hyperimmune bovine colostrum, making it exploitable as a functional food. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
20. Anti-zika virus activity of polyoxometalates.
- Author
-
Francese, Rachele, Civra, Andrea, Rittà, Massimo, Donalisio, Manuela, Argenziano, Monica, Cavalli, Roberta, Mougharbel, Ali S., Kortz, Ulrich, and Lembo, David
- Subjects
- *
POLYOXOMETALATES , *ZIKA virus infections , *ANTIVIRAL agents , *GUILLAIN-Barre syndrome , *PUBLIC health - Abstract
Abstract Zika virus (ZIKV) is an emerging infectious viral pathogen associated with severe fetal cerebral anomalies and the paralytic Guillain-Barrè syndrome in adults. It was the cause of a recent global health crisis following its entrance into a naïve population in the Americas. Nowadays, no vaccine or specific antiviral against ZIKV is available. In this study, we identified three polyoxometalates (POMs), the Anderson-Evans type [TeW 6 O 24 ]6- (TeW 6), and the Keggin-type [TiW 11 CoO 40 ]8-_ (TiW 11 Co), and [Ti 2 PW 10 O 40 ]7- (Ti 2 PW 10), that inhibit ZIKV infection with EC 50 s in the low micromolar range. Ti 2 PW 10 , the POM with the greatest selectivity index (SI), was selected and the step of ZIKV replicative cycle putatively inhibited was investigated by specific antiviral assays. We demonstrated that Ti 2 PW 10 targets the entry process of ZIKV infection and it is able to significantly reduce ZIKV progeny production. These results suggest that the polyanion Ti 2 PW 10 could be a good starting point to develop an effective therapeutic to treat ZIKV infection. Highlights • No vaccine or specific antiviral against ZIKV is available. • The polyoxometalates TeW 6 , TiW 11 Co and Ti 2 PW 10 showed a marked anti-ZIKV activity in vitro. • TeW 6 , TiW 11 Co and Ti 2 PW 10 are not toxic for cells. • Ti 2 PW 10 inhibits the entry process of ZIKV into the host cell. • Ti 2 PW 10 is able to significantly reduce ZIKV progeny production. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
21. The traditional use of Vachellia nilotica for sexually transmitted diseases is substantiated by the antiviral activity of its bark extract against sexually transmitted viruses.
- Author
-
Donalisio, Manuela, Cagno, Valeria, Civra, Andrea, Gibellini, Davide, Musumeci, Giuseppina, Rittà, Massimo, Ghosh, Manik, and Lembo, David
- Subjects
- *
VIRUS disease drug therapy , *ACYCLOVIR , *BARK , *CELL culture , *DRUG resistance in microorganisms , *HERPESVIRUSES , *HIV , *MICROBIAL sensitivity tests , *PAPILLOMAVIRUSES , *SEXUALLY transmitted diseases , *PLANT extracts , *IN vitro studies - Abstract
Ethnopharmacological relevance Vachellia (Acacia) nilotica and other plants of this genus have been used in traditional medicine of Asian and African countries to treat many disorders, including sexually transmitted diseases, but few studies were performed to validate their anti-microbial and anti-viral activity against sexually transmitted infections. Aim of the study The present study was undertaken to explore whether the ethnomedical use of V.nilotica to treat genital lesions is substantiated by its antiviral activity against the human immunodeficiency virus (HIV), the herpes simplex virus (HSV) and the human papillomavirus (HPV). Materials and methods The antiviral activity of V.nilotica was tested in vitro by virus-specific inhibition assays using HSV-2 strains, sensible or resistant to acyclovir, HIV-1IIIb strain and HPV-16 pseudovirion (PsV). The potential mode of action of extract against HSV-2 and HPV-16 was further investigated by virus inactivation and time-of-addition assays on cell cultures. Results V.nilotica chloroform, methanolic and water bark extracts exerted antiviral activity against HSV-2 and HPV-16 PsV infections; among these, methanolic extract showed the best EC50s with values of 4.71 and 1.80 µg/ml against HSV-2 and HPV-16, respectively, and it was also active against an acyclovir-resistant HSV-2 strain with an EC50 of 6.71 µg/ml. By contrast, no suppression of HIV infection was observed. Investigation of the mechanism of action revealed that the methanolic extract directly inactivated the infectivity of the HPV-16 particles, whereas a partial virus inactivation and interference with virus attachment (EC50 of 2.74 µg/ml) were both found to contribute to the anti-HSV-2 activity. Conclusions These results support the traditional use of V.nilotica applied externally for the treatment of genital lesions. Further work remains to be done in order to identify the bioactive components. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
22. Exploration of novel hexahydropyrrolo[1,2-e]imidazol-1-one derivatives as antiviral agents against ZIKV and USUV.
- Author
-
Chen, Ran, Francese, Rachele, Wang, Na, Li, Feng, Sun, Xia, Xu, Bin, Liu, Jinsong, Liu, Zhuyun, Donalisio, Manuela, Lembo, David, and Zhou, Guo-Chun
- Subjects
- *
ANTIVIRAL agents , *ZIKA virus , *ZIKA virus infections , *VIRAL proteins , *STRUCTURE-activity relationships , *VITAMIN D receptors , *VACCINE approval - Abstract
Zika virus (ZIKV) and Usutu virus (USUV) are two emerging flaviviruses mostly transmitted by mosquitos. ZIKV is associated with microcephaly in newborns and the less-known USUV, with its reported neurotropism and its extensive spread in Europe, represents a growing concern for human health. There is still no approved vaccine or specific antiviral against ZIKV and USUV infections. The main goal of this study is to investigate the anti-ZIKV and anti-USUV activity of a new library of compounds and to preliminarily investigate the mechanism of action of the selected hit compounds in vitro. Two potent anti-ZIKV and anti-USUV agents, namely ZDL-115 and ZDL-116 , were discovered, both presenting low cytotoxicity, cell-line independent antiviral activity in the low micromolar range and ability of reducing viral progeny production. The analysis of the structure-activity relationship (SAR) revealed that introduction of 2-deoxyribose to 3-arene was fundamental to enhance the solubility and improve the antiviral action. Additionally, we demonstrated that ZDL-115 and ZDL-116 are significantly active against both viruses when added on cells for at least 24 h prior to viral inoculation or immediately post-infection. The docking analysis showed that ZDL-116 could target the host vitamin D receptor (VDR) and viral proteins. Future experiments will be focused on compound modification to discover analogues that are more potent and on the clarification of the mechanism of action and the specific drug target. The discovery and the development of a novel anti-flavivirus drug will have a significant impact in a context where there are no fully effective antiviral drugs or vaccines for most flaviviruses. [Display omitted] • Two hexahydropyrrolo[1,2-e]imidazole-1-one derivatives are anti-flavivirus agents. • Introduction of 2-deoxyribose to 3-arene improves the inhibition of ZIKV and USUV. • ZDL-115 and ZDL-116 are able to reduce the production of infectious viral progeny. • Data suggested that the compounds exert both preventive and therapeutic activity. • Docking analysis showed that VDR and viral proteins are the binders of ZDL-116. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
23. The AGMA1 poly(amidoamine) inhibits the infectivity of herpes simplex virus in cell lines, in human cervicovaginal histocultures, and in vaginally infected mice.
- Author
-
Donalisio, Manuela, Quaranta, Paola, Chiuppesi, Flavia, Pistello, Mauro, Cagno, Valeria, Cavalli, Roberta, Volante, Marco, Bugatti, Antonella, Rusnati, Marco, Ranucci, Elisabetta, Ferruti, Paolo, and Lembo, David
- Subjects
- *
POLYAMIDOAMINE dendrimers , *HERPES simplex virus , *VAGINAL diseases , *CELL lines , *LABORATORY mice - Abstract
The development of topical microbicides is a valid approach to protect the genital mucosa from sexually transmitted infections that cannot be contained with effective vaccination, like HSV and HIV infections. A suitable target of microbicides is the interaction between viral proteins and cell surface heparan sulfate proteoglycans (HSPGs). AGMA1 is a prevailingly cationic agmatine-containing polyamidoamine polymer previously shown to inhibit HSPGs dependent viruses, including HSV-1, HSV-2, and HPV-16. The aim of this study was to elucidate the mechanism of action of AGMA1 against HSV infection and assess its antiviral efficacy and biocompatibility in preclinical models. The results show AGMA1 to be a non-toxic inhibitor of HSV infectivity in cell cultures and human cervicovaginal histocultures. Moreover, it significantly reduced the burden of infection of HSV-2 genital infection in mice. The investigation of the mechanism of action revealed that AGMA1 reduces cells susceptibility to virus infection by binding to cell surface HSPGs thereby preventing HSV attachment. This study indicates that AGMA1 is a promising candidate for the development of a topical microbicide to prevent sexually transmitted HSV infections. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
24. Ficus religiosa L. bark extracts inhibit human rhinovirus and respiratory syncytial virus infection in vitro.
- Author
-
Cagno, Valeria, Civra, Andrea, Kumar, Ravi, Pradhan, Subhankar, Donalisio, Manuela, Sinha, Barij Nayan, Ghosh, Manik, and Lembo, David
- Abstract
Ethnopharmacological relevance Ficus religiosa L. is one of the most relevant members of the family of Moraceae . It is the most sacred tree of South Asia, and it is used in traditional Ayurvedic and Unani medicine to cure respiratory disorders like cough, wheezing and asthma. Some studies were performed to investigate the anti-asthmatic potential of F. religiosa bark, leaves and fruit extracts but none of them tested their antiviral activity against viruses responsible for the exacerbation of wheezing and asthma. Aim of the study The present study was undertaken to investigate the antiviral activity of F. religiosa L. extracts against respiratory viruses such as human respiratory syncytial virus (RSV) and human rhinovirus (HRV). Materials and methods The antiviral activity of F. religiosa L. was tested in vitro by plaque reduction and virus yield assays and the major mechanism of action was investigated by virus inactivation and time-of-addition assays. Results F. religiosa L. methanol bark extract was the most active against HRV with an EC 50 of 5.52 µg/mL. This extract likely inhibited late steps of replicative cycle. Water bark extract was the most active against RSV with an EC 50 between 2.23 and 4.37 µg/mL. Partial virus inactivation and interference with virus attachment were both found to contribute to the anti-RSV activity. Replication of both viruses was inhibited in viral yield reduction assays. Conclusions The results of the present study demonstrate that F. religiosa L. is endowed with antiviral activity against RSV and HRV in vitro . Further work remains to be done to identify the active components and to assess the therapeutic potential in vivo . [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
25. 27-Hydroxycholesterol inhibits rhinovirus replication in vitro and on human nasal and bronchial histocultures without selecting viral resistant variants.
- Author
-
Civra, Andrea, Costantino, Matteo, Cavalli, Roberta, Adami, Marco, Volante, Marco, Poli, Giuseppe, and Lembo, David
- Subjects
- *
RHINOVIRUSES , *ANTIVIRAL agents , *CYSTIC fibrosis , *DRUG development , *OXYSTEROLS , *COMPETITIVE advantage in business , *BRONCHIAL arteries - Abstract
The genetic plasiticity of viruses is one of the main obstacles to the development of antivirals. The aim of this study has been to assess the ability of two physiologic oxysterols and host-targeting antivirals - namely 25- and 27-hydroxycholesterol (25OHC and 27OHC) - to select resistant strains, using human rhinovirus (HRV) as a challenging model of a viral quasispecies. Moreover, we selected 27OHC for further studies aimed at exploring its potential for the development of antiviral drugs. The results obtained with clonal or serial passage approaches show that 25OHC and 27OHC do not select HRV oxysterol-resistant variants. Moreover, we demonstrate the ability of 27OHC to inhibit the yield of HRV in 3D in vitro fully reconstituted human nasal and bronchial epithelia from cystic fibrosis patients and prevent virus-induced cilia damage. The promising antiviral activity of 27OHC and its competitive advantages over direct-acting antivirals, make this molecule a suitable candidate for further studies to explore its clinical potential. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
26. In vitro evaluation of the antiviral properties of Shilajit and investigation of its mechanisms of action.
- Author
-
Cagno, Valeria, Donalisio, Manuela, Civra, Andrea, Cagliero, Cecilia, Rubiolo, Patrizia, and Lembo, David
- Subjects
- *
MINERAL analysis , *ALTERNATIVE medicine , *ANTIVIRAL agents , *BIOLOGICAL assay , *CYTOMEGALOVIRUSES , *DOSE-effect relationship in pharmacology , *HERPESVIRUSES , *AYURVEDIC medicine , *MICROBIAL sensitivity tests , *MINERALS , *RESPIRATORY syncytial virus , *ROTAVIRUSES , *DESCRIPTIVE statistics , *IN vitro studies , *PHARMACODYNAMICS - Abstract
Ethnopharmacological relevance Shilajit, a herbomineral substance exuded from rocks in steep mountainous regions, has been used for thousands of years by the Indian Ayurvedic and Siddha systems of traditional medicine to relieve ailments and enhance quality of life. Although a large number of therapeutic properties have been ascribed to Shilajit, its therapeutic potential is still largely unexplored by modern research and many of its claimed bioactivities lack scientific validation. The present study was undertaken to investigate the antiviral activity of Shilajit against a panel of viruses including herpes simplex type 1 and 2 (HSV-1, HSV-2), human cytomegalovirus (HCMV), human respiratory syncytial virus (RSV), human rotavirus (HRV), and vesicular stomatitis virus (VSV). Materials and methods The antiviral activity of Shilajit was assayed in vitro by plaque reduction and virus yield assays and the major mechanism of action was investigated by virucidal and time-of-addition assays. Results Shilajit exhibited a dose-dependent inhibitory activity against HSV1, HSV2, HCMV, and RSV infectivity in vitro (EC 50 values: 31.08 μg/ml, 12.85 μg/ml, 34.54 μg/ml, and 30.35 μg/ml, respectively), but was inactive against HRV and VSV. Humic acid, a constituent of Shilajit, displayed the same spectrum of activity. Partial virus inactivation and interference with virus attachment were both found to contribute to the antiviral activity of Shilajit. Conclusions The results of the present study demonstrate that Shilajit is endowed with broad, yet specific, antiviral activity in vitro and constitutes a natural source of antiviral substances. Further work remains to be done to assess its efficacy in vivo . [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
27. Identification of Equine Lactadherin-derived Peptides That Inhibit Rotavirus Infection via Integrin Receptor Competition.
- Author
-
Civra, Andrea, Giuffrida, Maria Gabriella, Donalisio, Manuela, Napolitano, Lorenzo, Yoshikazu Takada, Coulson, Barbara S., Conti, Amedeo, and Lembo, David
- Subjects
- *
MILKFAT , *PEPTIDES , *ROTAVIRUSES , *INTEGRINS , *GLYCOPROTEINS , *GASTROENTERITIS - Abstract
Human rotavirus is the leading cause of severe gastroenteritis in infants and children under the age of 5 years in both developed and developing countries. Human lactadherin, a milk fat globule membrane glycoprotein, inhibits human rotavirus infection in vitro, whereas bovine lactadherin is not active. Moreover, it protects breastfed infants against symptomatic rotavirus infections. To explore the potential antiviral activity of lactadherin sourced by equines, we undertook a proteomic analysis of milk fat globule membrane proteins from donkey milk and elucidated its amino acid sequence. Alignment of the human, bovine, and donkey lactadherin sequences revealed the presence of an Asp-Gly-Glu (DGE) α2β1 integrin-binding motif in the N-terminal domain of donkey sequence only. Because integrin α2β1 plays a critical role during early steps of rotavirus host cell adhesion, we tested a minilibrary of donkey lactadherin- derived peptides containing DGE sequence for anti-rotavirus activity. A 20-amino acid peptide containing both DGE andRGDmotifs (named pDGE-RGD) showed the greatest activity, and its mechanism of antiviral action was characterized; pDGE-RGD binds to integrin α2β1 by means of the DGE motif and inhibits rotavirus attachment to the cell surface. These findings suggest the potential anti-rotavirus activity of equine lactadherin and support the feasibility of developing an anti-rotavirus peptide that acts by hindering virus-receptor binding. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
28. Sulfated K5 Escherichia coli polysaccharide derivatives: A novel class of candidate antiviral microbicides
- Author
-
Rusnati, Marco, Vicenzi, Elisa, Donalisio, Manuela, Oreste, Pasqua, Landolfo, Santo, and Lembo, David
- Subjects
- *
ANTIVIRAL agents , *ESCHERICHIA coli , *VIRAL proteins , *SEXUALLY transmitted diseases , *MICROBIAL polysaccharides , *HOST-virus relationships , *CELL-mediated cytotoxicity , *CLINICAL trials , *SULFATES - Abstract
Abstract: Antiviral microbicides, topical agents that prevent sexually transmitted infections, mainly work by blocking the interaction between viral proteins and cell surface components. In many instances, virus–cell interaction is mediated by cell surface heparan sulfate proteoglycans (HSPGs). HSPGs are exploited as attachment receptors by three sexually transmitted viruses: Human Immunodeficiency Virus (HIV), Herpes Simplex Virus (HSV) and Human Papilloma Virus (HPV). Since these viruses can either infect or co-infect humans, virus/HSPGs interaction is a preferential target for the development of wide-spectrum antiviral microbicides. Several polyanionic compounds prevent HIV, HSV and HPV infections in cell culture models by acting as heparan sulfate (HS)-antagonists. However, three promising polyanionic compounds recently failed to pass phase III clinical trials designed to establish their efficacy in preventing HIV acquisition. In this scenario, new polyanionic compounds must be added to the pipeline of candidate microbicides and their development as effective drugs reconsidered. The capsular K5 polysaccharide from Escherichia coli has the same structure as the heparin/HS biosynthetic precursor. Chemical and enzymatic modifications have led to the synthesis of K5 derivatives with different degrees of sulfation and charge distribution and devoid of anticoagulant activity and cell toxicity. Recently attracting attention as candidate microbicides, they potently inhibit a broad spectrum of HIV-1 strains and genital types of HPV and HSV-1 and 2 in vitro. With a focus on the K5 derivatives, this article reviews the literature on polyanions as antiviral microbicides and discusses the possible therapeutic implications of this novel class of compounds. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
29. TGF-β1 and IL-4 downregulate human papillomavirus-16 oncogene expression but have differential effects on the malignant phenotype of cervical carcinoma cells
- Author
-
Donalisio, Manuela, Cornaglia, Maura, Landolfo, Santo, and Lembo, David
- Subjects
- *
PAPILLOMAVIRUSES , *IMMUNOREGULATION , *CYTOKINES , *CELLULAR immunity - Abstract
Abstract: Host immune response to human papillomavirus (HPV) is a crucial factor in viral clearance and control of persistent infections. The existence of an intercellular control mechanism mediated by cytokines to suppress HPV-gene transcription and to prevent malignant conversion of HPV-infected cells, has been postulated. In a previous study, we demonstrated the inhibitory activity of several cytokines on the HPV-16 long control region (LCR)-driven transcription; among these, IL-4 was reported as a LCR inhibitor for the first time and proposed as a candidate for further studies. Here, we addressed the question of whether IL-4 represses HPV-16 oncogene transcription and exerts antitumor activity in HPV-16 positive cervical carcinoma cell lines. Results indicated that downregulation of E6 and E7 levels by IL-4 in CaSki cells is weaker than that exerted by TGF-β1, a known LCR inhibitor, although both cytokines are equally active in suppressing LCR-driven transcriptional activity in a reporter cell line. Moreover, only TGF-beta rescued p53 expression, Rb response pathway, and induced cellular senescence. SiHa cells were unresponsive to both cytokines. These findings suggest that the two cytokines may play a role in the control of HPV infections, however, cervical carcinoma cells developed a partial or a total resistance to their inhibitory activity. [Copyright &y& Elsevier]
- Published
- 2008
- Full Text
- View/download PDF
30. The human cytomegalovirus
- Author
-
Landolfo, Santo, Gariglio, Marisa, Gribaudo, Giorgio, and Lembo, David
- Subjects
- *
CYTOMEGALOVIRUS diseases , *HUMAN abnormalities - Abstract
Human cytomegalovirus (HCMV), a betaherpesvirus, represents the major infectious cause of birth defects, as well as an important pathogen for immunocompromised individuals. The viral nucleocapsid containing a linear double-stranded DNA of 230 kb is surrounded by a proteinaceous tegument, which is itself enclosed by a loosely applied lipid bilayer. Expression of the HCMV genome is controlled by a cascade of transcriptional events that leads to the synthesis of three categories of viral proteins designated as immediate-early, early, and late. Clinical manifestations can be seen following primary infection, reinfection, or reactivation. About 10% of infants are infected by the age of 6 months following transmission from their mothers via the placenta, during delivery, or by breastfeeding. HCMV is a significant post-allograft pathogen and contributes to graft loss independently from graft rejection. Histopathologic examination of necropsy tissues demonstrates that the virus enters via the epithelium of the upper alimentary, respiratory, or genitourinary tracts. Hematogenous spreading is typically followed by infection of ductal epithelial cells. Infections are kept under control by the immune system. However, total HCMV clearance is rarely achieved, and the viral genome remains at selected sites in a latent state. Virological and molecular detection of HCMV, as well as serological demonstration of a specific immune response, are used for diagnosis. Treatment of HCMV infections is difficult because there are few options. The presently available drugs produced a significant clinical improvement, but suffer from poor oral bioavailability, low potency, development of resistance in clinical practice, and dose-limiting toxicities. [Copyright &y& Elsevier]
- Published
- 2003
- Full Text
- View/download PDF
31. Trend of 25-hydroxycholesterol and 27-hydroxycholesterol plasma levels in patients affected by active chronic hepatitis B virus infection and inactive carriers.
- Author
-
Boglione, Lucio, Caccia, Claudio, Civra, Andrea, Cusato, Jessica, D'Avolio, Antonio, Biasi, Fiorella, Lembo, David, Di Perri, Giovanni, Poli, Giuseppe, and Leoni, Valerio
- Subjects
- *
HEPATITIS B , *CHRONIC active hepatitis , *HEPATITIS B virus , *INVERSE relationships (Mathematics) , *OXYSTEROLS - Abstract
• The plasma levels of 25OHC and 27OHC were significantly higher in inactive carrier (IC) subjects than in patients with active chronic hepatitis B (CHB). • A highly significant inverse correlation was observed between 25OHC and 27OHC plasma levels and the qHBsAg serum levels. • A significant inverse correlation was also observed between liver stiffness measurement and both 25OHC and 27OHC plasma concentrations. • ROC curve analysis demonstrated that plasma level of 27OHC ≥ 140 μg/L was predictive of the IC condition. Hepatitis B virus (HBV) infection is a global health problem with different immunological phases and therapeutic approaches. The serological condition of inactive carrier (IC) was recently well defined as a clinical and virological stable status, in which specific treatment is usually deferred, while the active chronic hepatitis B (CHB) condition requires an immediate treatment strategy. Recently, a possible broad antiviral effect of oxysterols, in particular 25-hydroxycholesterol (25OHC) and 27-hydroxycholesterol (27OHC), was observed, as most likely linked to the positive modulation of innate immunity, but no clear evidence is available about their possible role in chronic HBV infection. Thus, we examined the relationship between the plasma levels of oxysterols and the disease condition of 40 HBV patients, without treatment at the start of the study. Of these, 33 were ICs and 7 were active CHB subjects. A marked reduction of 25OHC and 27OHC plasma levels was detectable in all active CHB recruited patients, while the plasma values observed in ICs all remained within the physiological range. No difference was observed between the two groups of patients with regard to the plasma levels of 24-hydroxycholesterol (24OHC). Further, the plasma level of 27OHC ≥ 140 μg/L was shown to be predictive of an inactive carrier status. This cohort study points to 27OHC as a good candidate biomarker to differentiate active and inactive CHB status. An increasing bulk of research reports is supporting the very likely contribution of this oxysterol to the immunological control of chronic hepatitis B. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
32. Combined in silico and in vitro approaches identified the antipsychotic drug lurasidone and the antiviral drug elbasvir as SARS-CoV2 and HCoV-OC43 inhibitors.
- Author
-
Milani, Mario, Donalisio, Manuela, Bonotto, Rafaela Milan, Schneider, Edoardo, Arduino, Irene, Boni, Francesco, Lembo, David, Marcello, Alessandro, and Mastrangelo, Eloise
- Subjects
- *
SARS-CoV-2 , *ANTIVIRAL agents , *RNA replicase , *COMMON cold , *COVID-19 pandemic , *COVID-19 - Abstract
The current emergency of the novel coronavirus SARS-CoV2 urged the need for broad-spectrum antiviral drugs as the first line of treatment. Coronaviruses are a large family of viruses that already challenged humanity in at least two other previous outbreaks and are likely to be a constant threat for the future. In this work we developed a pipeline based on in silico docking of known drugs on SARS-CoV1/2 RNA-dependent RNA polymerase combined with in vitro antiviral assays on both SARS-CoV2 and the common cold human coronavirus HCoV-OC43. Results showed that certain drugs displayed activity for both viruses at a similar inhibitory concentration, while others were specific. In particular, the antipsychotic drug lurasidone and the antiviral drug elbasvir showed promising activity in the low micromolar range against both viruses with good selectivity index. • In silico docking selection of 13 known drugs. • Antiviral testing on SARS-CoV2 and HCoV-OC43 infected cells. • The antipsychotic drug lurasidone and the antiviral drug elbasvir inhibit both SARS-CoV2 and HCoV-OC43. • Alectinib is a good and selective inhibitor of HCoV-OC43 infected cells. • Grazoprevir is a selective inhibitor of SARS-CoV2. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
33. Antiviral oxysterols are present in human milk at diverse stages of lactation.
- Author
-
Civra, Andrea, Leoni, Valerio, Caccia, Claudio, Sottemano, Stefano, Tonetto, Paola, Coscia, Alessandra, Peila, Chiara, Moro, Guido E., Gaglioti, Pietro, Bertino, Enrico, Poli, Giuseppe, and Lembo, David
- Subjects
- *
OXYSTEROLS , *LACTATION , *BREAST milk , *COLOSTRUM , *HYDROXYL group , *STEROLS , *CHOLESTEROL - Abstract
• This study discloses new antiviral components of human milk. • 24HC, 25HC, and 27HC are oxysterols present in human milk at any stage of lactation. • 27HC content in colostrum is remarkably higher than that of 24HC and 25HC. • 27HC concentrations in colostrum are potentially active against HRoV and HRhV. Oxysterols are cholesterol oxidation derivatives. Those containing an additional hydroxyl group on the side chain of the cholesterol molecule result from a physiological enzymatic synthesis and include the majority of oxysterols present in the circulation. Among these, 25-hydroxycholesterol (25OHC) and 27-hydroxycholesterol (27OHC) are characterized by a broad antiviral activity and are now considered involved in the innate immune response against viruses. Despite the emerging role of these sterols in the innate antiviral defences, no data are available on their presence in human breast milk (BM) to date. In this study, we investigated the content of oxysterols of enzymatic synthesis in BM of twelve donor mothers at different stages of lactation (i.e. in colostrum, transitional milk, and mature milk) by gas chromatography-mass spectrometry analysis. The side-chain oxysterols 25OHC, 27OHC, and 24S-hydroxycholesterol (24SOHC) were actually present in BM in all stages of lactation, but the concentration of 27OHC showed a remarkable peak in colostrum. Antiviral assays revealed that all the colostrum samples contained 27OHC concentrations that were active in vitro against two relevant pediatric viral pathogens: the human rotavirus and the human rhinovirus. Overall, this study discloses new antiviral components of BM and suggests a passive transfer of these protective factors to the infant via breastfeeding, especially in the first few days of lactation. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.